Literature DB >> 1381505

Targeted cleavage of mRNA by human RNase P.

Y Yuan1, E S Hwang, S Altman.   

Abstract

Ribonuclease P from Escherichia coli can cleave RNAs in simple, hydrogen-bonded complexes of two oligoribonucleotides that resemble the aminoacyl stem and 5' leader sequence of tRNA precursors. RNase P from human (HeLa) cells cannot catalyze the cleavage in vitro of the 5'-proximal oligoribonucleotide that contains the leader sequence in such simple complexes but can do so when the 3'-proximal oligoribonucleotide (external guide sequence) is altered to resemble three-quarters of a tRNA molecule. In such a complex, the efficiency of cleavage of the mRNA for chloramphenicol acetyltransferase, as the 5'-proximal oligoribonucleotide, depends on the structural details of the external guide sequence and on the choice of target site within the mRNA. The presence of the appropriately designed external guide sequence in cells in tissue culture reduces chloramphenicol acetyltransferase activity and the level of the corresponding intact mRNA in the cells. Thus, it appears that the use of such external guide sequences may provide a general technique for gene inactivation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1381505      PMCID: PMC49844          DOI: 10.1073/pnas.89.17.8006

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  11 in total

1.  External guide sequences for an RNA enzyme.

Authors:  A C Forster; S Altman
Journal:  Science       Date:  1990-08-17       Impact factor: 47.728

2.  Model substrates for an RNA enzyme.

Authors:  W H McClain; C Guerrier-Takada; S Altman
Journal:  Science       Date:  1987-10-23       Impact factor: 47.728

3.  Structural analysis of the human U3 ribonucleoprotein particle reveal a conserved sequence available for base pairing with pre-rRNA.

Authors:  K A Parker; J A Steitz
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

4.  Activation of the human beta-interferon gene requires an interferon-inducible factor.

Authors:  T Enoch; K Zinn; T Maniatis
Journal:  Mol Cell Biol       Date:  1986-03       Impact factor: 4.272

5.  Identification of two distinct regulatory regions adjacent to the human beta-interferon gene.

Authors:  K Zinn; D DiMaio; T Maniatis
Journal:  Cell       Date:  1983-10       Impact factor: 41.582

6.  DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells.

Authors:  M Wigler; A Pellicer; S Silverstein; R Axel; G Urlaub; L Chasin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

7.  Identification and characterization of an RNA molecule that copurifies with RNase P activity from HeLa cells.

Authors:  M Bartkiewicz; H Gold; S Altman
Journal:  Genes Dev       Date:  1989-04       Impact factor: 11.361

8.  Targeted cleavage of mRNA in vitro by RNase P from Escherichia coli.

Authors:  Y Li; C Guerrier-Takada; S Altman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

9.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

10.  Upstream regulatory elements are necessary and sufficient for transcription of a U6 RNA gene by RNA polymerase III.

Authors:  G Das; D Henning; D Wright; R Reddy
Journal:  EMBO J       Date:  1988-02       Impact factor: 11.598

View more
  58 in total

1.  Effective inhibition of human cytomegalovirus gene expression and replication by a ribozyme derived from the catalytic RNA subunit of RNase P from Escherichia coli.

Authors:  P Trang; M Lee; E Nepomuceno; J Kim; H Zhu; F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

2.  Cross-clade inhibition of HIV-1 replication and cytopathology by using RNase P-associated external guide sequences.

Authors:  Gunter Kraus; Rebeca Geffin; Gina Spruill; Andrea K Young; Rachel Seivright; Diana Cardona; Jennifer Burzawa; H James Hnatyszyn
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

3.  Coordinate inhibition of expression of several genes for protein subunits of human nuclear RNase P.

Authors:  Elizaveta Kovrigina; Donna Wesolowski; Sidney Altman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

Review 4.  Of proteins and RNA: the RNase P/MRP family.

Authors:  Olga Esakova; Andrey S Krasilnikov
Journal:  RNA       Date:  2010-07-13       Impact factor: 4.942

Review 5.  Gene therapeutic approaches to inhibit hepatitis B virus replication.

Authors:  Maren Gebbing; Thorsten Bergmann; Eric Schulz; Anja Ehrhardt
Journal:  World J Hepatol       Date:  2015-02-27

6.  Chloromycetin resistance of clinically isolated E coli is conversed by using EGS technique to repress the chloromycetin acetyl transferase.

Authors:  Mei-Ying Gao; Chuan-Rui Xu; Ru Chen; Shou-Gui Liu; Jiang-Nan Feng
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

Review 7.  Inhibition of gene expression in human cells using RNase P-derived ribozymes and external guide sequences.

Authors:  Kihoon Kim; Fenyong Liu
Journal:  Biochim Biophys Acta       Date:  2007-09-29

8.  Rapid selection of accessible and cleavable sites in RNA by Escherichia coli RNase P and random external guide sequences.

Authors:  Eirik W Lundblad; Gaoping Xiao; Jae-Hyeong Ko; Sidney Altman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-08       Impact factor: 11.205

9.  Artificial regulation of gene expression in Escherichia coli by RNase P.

Authors:  C Guerrier-Takada; Y Li; S Altman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

10.  Inhibition of expression of virulence genes of Yersinia pestis in Escherichia coli by external guide sequences and RNase P.

Authors:  Jae-hyeong Ko; Mina Izadjoo; Sidney Altman
Journal:  RNA       Date:  2008-06-20       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.